Fred Hassan, a partner and managing director of Warburg Pincus LLC, has joined the board of directors of Amgen Inc and will sit on the audit committee and the compensation and management development committee.
Mr Hassan was formerly chairman and chief executive officer of Schering-Plough Corporation until that company was acquired by Merck & Co. Inc in 2009. Before this, he was president and CEO of Pharmacia Corporation which became part of Pfizer in 2003. Mr Hassan also held various roles at Sandoz Pharmaceuticals including heading its US pharmaceuticals’ business.
Amgen announced the appointment on 30 July 2015.
Copyright 2015 Evernow Publishing Ltd